. "1" . "4"^^ . "C\u00EDlem na\u0161\u00ED pr\u00E1ce bylo ov\u011B\u0159it klinickou prosp\u011B\u0161nost syst\u00E9mu Roche MagNa Pure k extrakci lidsk\u00E9 geonomov\u00E9 DNA z krve a porovnat tento syst\u00E9m s mikrokolonov\u00FDm extrak\u010Dn\u00EDm syst\u00E9mem Quiagen. Zkoumali jsme MagNa Pure LC izola\u010Dn\u00ED set DNA I na MagNa Pure LC Instrument. P\u0159esnost kvantitativn\u00EDho rozboru ur\u010Den\u00E1 z nahromad\u011Bn\u00FDch krevn\u00EDch vzork\u016F byla 5.4 % a ka\u017Edodenn\u00ED p\u0159esnost byla 7.8 %. \u010Cistota DNA byla 1.9 +- 0.1. Pr\u016Fm\u011Brn\u00E1 n\u00E1vratnost v rozmez\u00ED DNA byla 2.2 \u2013 35.0 \u00B5g byla 43 %. Srovn\u00E1n\u00ED extrak\u010Dn\u00EDho procesu MagNa Pure s Quiagen procesem, kter\u00E9 bylo provedeno u 32 vzork\u016F krve, poskytlo statisticky velmi podobn\u00E9 mno\u017Estv\u00ED DNA (6.2 +- 1.0 vs. 6.5 +- 1.0 \u00B5g). T\u0159i r\u016Fzn\u00E1 real-time PCR, vyhodnocen\u00E1 pr\u016Fse\u010D\u00EDkovou anal\u00FDzou, prok\u00E1zala podobn\u00E9 profily zv\u011Bt\u0161en\u00ED. Oba srovn\u00E1van\u00E9 extrak\u010Dn\u00ED syst\u00E9my poskytuj\u00ED DNA vysok\u00E9 kvality, \u010Distoty a PCR umocnitelnosti. N\u00E1stroj MagNa p\u0159isp\u00EDv\u00E1 ke spolehliv\u00E9mu a snadn\u00E9mu z\u00EDsk\u00E1v\u00E1n\u00ED DNA vzork\u016F pro dal\u0161\u00ED molekul\u00E1rn\u00ED anal\u00FDzy."@cs . "CZ - \u010Cesk\u00E1 republika" . "1210-7921" . . "Pali\u010Dka, Vladim\u00EDr" . . . "4"^^ . "MagNa Pure System for DNA Extraction from Whole Blood. Clinical Verification of Pre-Analytical Phase of DNA Testing"@en . . . "2"^^ . . "MagNa Pure syst\u00E9m na extrakci DNA z pln\u00E9 krve. Klinick\u00E1 verifikace preanalytick\u00E9 f\u00E1ze testov\u00E1n\u00ED DNA"@cs . "11150" . "Ber\u00E1nek, Martin" . "13" . "The objective of our work was to verify the clinical usefulness of Roche MagNA Pure system for extraction of human genomic DNA from whole blood, and to compare it to Qiagen microcolumn-based extraction system. We examined the MagNA Pure LC DNA Isolation Kit I on the MagNA Pure LC Instrument. Both compared extraction systems provide DNA of high quantity, purity and PCR amplificability. The MagNA Pure instrument contributes to reliable and comfortable preparation of DNA samples for consequent molecular analyses." . "528591" . "RIV/00216208:11150/05:00004993!RIV08-MSM-11150___" . . . "Klinick\u00E1 biochemie a metabolismus" . . "10;13" . "MagNa Pure System for DNA Extraction from Whole Blood. Clinical Verification of Pre-Analytical Phase of DNA Testing" . . . "[8FD2BF7C6F25]" . "MagNa; System; Extraction; Whole; Blood; Clinical; Verification; Pre-Analytical; Phase; Testing"@en . . "MagNa Pure System for DNA Extraction from Whole Blood. Clinical Verification of Pre-Analytical Phase of DNA Testing" . . . "S" . . . "MagNa Pure syst\u00E9m na extrakci DNA z pln\u00E9 krve. Klinick\u00E1 verifikace preanalytick\u00E9 f\u00E1ze testov\u00E1n\u00ED DNA"@cs . "RIV/00216208:11150/05:00004993" . "MagNa Pure System for DNA Extraction from Whole Blood. Clinical Verification of Pre-Analytical Phase of DNA Testing"@en . . "The objective of our work was to verify the clinical usefulness of Roche MagNA Pure system for extraction of human genomic DNA from whole blood, and to compare it to Qiagen microcolumn-based extraction system. We examined the MagNA Pure LC DNA Isolation Kit I on the MagNA Pure LC Instrument. Both compared extraction systems provide DNA of high quantity, purity and PCR amplificability. The MagNA Pure instrument contributes to reliable and comfortable preparation of DNA samples for consequent molecular analyses."@en . . . . .